Sample Article - Update on Transdermals for Animal Patients

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Jul/Aug 2001 Pg. 282-283	Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole Author(s): Davidson Gigi S
May/Jun 2005 Pg. 229	Methimazole 10-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
Jan/Feb 2019 Pg. 56	Methimazole 5 mg/0.1 mL in Pluronic Lecithin Organogel Gel, Veterinary Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 366-369	To Compound or Not to Compound: A Veterinary Transdermal Discussion Author(s): Eichstadt Lauren R, Davidson Gigi S
Jul/Aug 2014 Pg. 332-340	Evaluation of Percutaneous Absorption Performance for Human Female Sexual Steroids into Pentravan Cream Author(s): Polonini Hudson C, Brandão Marcos Antônio F, Ferreira Anderson O, Ramos Cristiano, Raposo Nádia R B
Sep/Oct 2002 Pg. 344-345	Transdermal Methimazole in the Treatment of 16 Cats with Hyperthyroidism Author(s): Wingate Gary
Jan/Feb 2017 Pg. 19-21	When to Compound Medications for Veterinary Patients Author(s): Forsythe Lauren Eichstadt
Sep/Oct 2019 Pg. 422-427	The Current Landscape of Veterinary Compounding in the Pharmacy Setting Author(s): Gochenauer Alexandria E, Holmes Erin R, Barber Katie E, Forsythe Lauren R
Sep/Oct 2019 Pg. 428-433	The Current Landscape of Veterinary Compounding in the Veterinary Setting Author(s): Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Jul/Aug 2000 Pg. 264-272	Providing Positive Outcomes through Compounding for Animal Cancer Patients Author(s): Davidson Gigi S
May/Jun 2005 Pg. 178-182 View Sample	Update on Transdermals for Animal Patients Author(s): Davidson Gigi S
Nov/Dec 2010 Pg. 522-525	Stability of Methimazole in Poloxamer Lecithin Organogel to Determine Beyond-Use Date Author(s): Pignato Alyssa, Pankaskie Marvin, Birnie Christine
Jul/Aug 2010 Pg. 301-304	Considerations for Percutaneous Absorption Author(s): Newton Stephen J, Cook Jennifer M
Sep/Oct 2009 Pg. 358-360	Transdermal Dosing Considerations for Veterinarians Author(s): Williams KaCee D
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
May/Jun 2016 Pg. 250-256	Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives Author(s): Trimble John, Light Bob
Jan/Feb 2026 Pg. 6-11	Between Necessity and Compliance: Understanding FDA’s GFI #256 for Animal Drug Compounding Author(s): Vogel Jordan T, Howard Brad
Sep/Oct 2009 Pg. 390-391	Recommended Tips for Treating Veterinary Patients Author(s): Bramwell Bethany L, Williams LaVonn A
Mar/Apr 2001 Pg. 86-88	The Use of Psychoactive Agents in Veterinary Medicine Author(s): Simpson Barbara S
Mar/Apr 2001 Pg. 95-96	Evaluating Transdermal Medication Forms for Veterinary Patients, Part 1 Author(s): Davidson Gigi S
May/Jun 2012 Pg. 248-252	In Vitro Percutaneous Absorption of Ketoprofen and Testosterone: Comparison of Pluronic Lecithin Organogel vs. Pentravan Cream Author(s): Lehman Paul A, Raney Sam G
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
May/Jun 2005 Pg. 185-192	Compounding for Behavior Problems in Animals Author(s): Vail Jane, Davidson Gigi S
Jan/Feb 2009 Pg. 42-49	Compounding for Cancer in Companion Animals Author(s): Mixon William, Northrup Nicole, Vail Jane
Jan/Feb 2019 Pg. 65-69	Transdermal Delivery of Metformin Hydrochloride from a Semisolid Vehicle Author(s): Polonini Hudson, Lopes Cândido Paulo José, Andrade Junquiera Laura, Loures Sharlene, Raposo Nádia RB, Fernandes Brandão Marcos Antônio, de Oliveira Ferreira Anderson
May/Jun 2014 Pg. 256-261	Preparation and In Vitro Evaluation of a Pluronic Lecithin Organogel Containing Ricinoleic Acid for Transdermal Delivery Author(s): Boddu Sai HS, Bonam Sindhu Prabha, Wei Yangjie, Alexander Kenneth
Sep/Oct 2023 Pg. 424-430	Evaluation of Compounded Transdermal Analgesic Formulations Using the Franz Finite Dose Model Author(s): Baneshi Marzieh, Tyagi Deependra, Panneerselvam Ezilrani, MacKenzie Graham, Coleman Johngary, Zhang Shine X
May/Jun 2005 Pg. 247-248	PostScription: AVMA's Position on Compounding for Animals Author(s): Riddell M Gatz
Jul/Aug 1997 Pg. 230-231	Compounding for Animals: The AVMA Perspective Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 392-397	Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases Author(s): Mixon William, Helms Scott R
Nov/Dec 2006 Pg. 418	Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety Author(s): Fields Shannon W
Sep/Oct 2021 Pg. 422-426	Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application Author(s): Polonini Hudson, de Oliveira Ferreira Anderson, Dijkers Eli
Nov/Dec 2022 Pg. 468-472	Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
Mar/Apr 2015 Pg. 152-160	Transdermal Delivery of Nisoldipine: Refinement of Vehicles Author(s): El Maghraby Gamal M, Ahmed Amal A, Osman Mohamed A
Jul/Aug 2016 Pg. 271-274	Compounding Transdermal Medication for Feline Patients Author(s): Eichstadt Lauren R
Nov/Dec 2017 Pg. 446-452	Feline Transdermal Formulation Considerations Author(s): Forsythe Lauren Eichstadt
Nov/Dec 2013 Pg. 520-525	Ex Vivo Percutaneous Absorption of Ketamine, Bupivacaine, Diclofenac, Gabapentin, Orphenadrine, and Pentoxyifylline: Comparison of Versatile Cream vs. Reference Cream Author(s): Wang Xuexuan, Black Laura
Sep/Oct 2009 Pg. 356	PreScription: Veterinary Pharmacy Author(s): Allen Loyd V Jr
Sep/Oct 2010 Pg. 358	PreScription: Compounding Veterinary Products: Needed but Problematic Author(s): Menighan Thomas E
May/Jun 2010 Pg. 241	Carprofen 2.5-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2010 Pg. 249	Voriconazole 40-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2019 Pg. 149	Dexamethasone 2 mg/g Topical Paste, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 232	Ursodiol 100 mg/mL in Cod Liver Oil, Veterinary Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 417-418	Compounding for Veterinary Medicine Author(s): Fields Shannon W
Jul/Aug 1997 Pg. 222-227	Veterinary Compounding: A Bird's Eye View Author(s): Jordan Dinah G
Jul/Aug 1997 Pg. 228	Suggested Flavors for Veterinary Medications Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 511	Enrofloxacin 11.35 mg/mL in Ora-Blend, Veterinary Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 276-286	Compounding Prokinetic Medications for Companion Animals Author(s): Gaskins Jessica
Jan/Feb 2026 Pg. 12-21	Case Series of Veterinary Cancer Patients Treated with Oral Low-Dose Naltrexone Author(s): Garza Meagan A, Hoffart Steve, Parsons-Doherty Melissa, Clark Deborah H, Banov Fabiana, Carvalho Maria
Jul/Aug 1997 Pg. 242-243	Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease Author(s): Patterson Donna, Ford Peter R, Gallon Marlene D
Nov/Dec 2006 Pg. 449	Calculations: Compounding for Large and Small Animals Author(s): Stockton Shelly J
May/Jun 2005 Pg. 195-198	Compounding Antiangiogenic Cancer Therapy for Animals Author(s): Davidson Gigi S
Jul/Aug 2000 Pg. 304	Nasogastric Tube/Percutaneous Endoscopic Gastrostomy Tube Suspension Formula Author(s): Allen Loyd V Jr
Nov/Dec 2016 Pg. 526-527	PostScription: What Lies Beneath: Potentially Harmful Excipients to Avoid when Compounding for Small Animals--A Note of Caution Author(s): Rost Erika
Mar/Apr 2001 Pg. 132	Methimazole 5-mg/0.1-mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 183	Methimazole 5 mg/0.1 mL in PLO (Vet) Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 182-186	Bracketed Stability Evaluation of Methimazole USP in PLO Gel Mediflo™30 Pre-Mixed Author(s): Tran Anh, Hunt Kathryn, Bernal Claude III, Cull Erica
Mar/Apr 2024 Pg. 131	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
Nov/Dec 2023 Pg. 494-502	Pathophysiology and Management of Onychomycosis and Novel Approaches for Effective Transdermal Applications Author(s): Dharmian Jose Prakash, Sathiyaseelan Iraniammal, Renganathan Akshaya, Mubees Alamaan Mohamed, Naser Mohammed Yasin Abdul, Ramkrishnan Prakash, Arumugam Somasundaram
Mar/Apr 2026 Pg. 158-173	Chemical and Microbiological Stability Supporting Extended BUDs in Pentravan® Based Transdermal Preparations Author(s): Polonini Hudson, Kegele Carolina Schettino, Marianni Bruna
Sep/Oct 2006 Pg. 392-395	In Vitro Transdermal Diffusion of Zileuton from a Topical Gel Author(s): Bigeleisen Paul E
May/Jun 2007 Pg. 181-184	Transdermal Gel in the Treatment of Postoperative Pain Author(s): Alexander Kayla, Wynn Tom
May/Jun 2022 Pg. 214-217	Basics of Compounding: Vehicle for Drug Administration via Enteral Feeding Tubes Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 110-114	Bilateral Areolar Hyperpigmentation Following Transdermal Administration of Compounded Hormone Replacement Therapy Author(s): Griffee Chris, Delano Amy
Mar/Apr 2011 Pg. 157	Amitriptyline Hydrochloride 2%, Carbamazepine 2%, Gabapentin 10%, and Ketoprofen 2% Transdermal Gel Author(s): Allen Loyd V Jr
May/Jun 2011 Pg. 200-203	Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Author(s): Wynn Tom, Goetsch Daniel
Jan/Feb 2012 Pg. 62-63	The Use of Pluronic Lecithin Organogels in the Transdermal Delivery of Drugs Author(s): Bramwell Bethany L, Williams LaVonn A
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Nov/Dec 2009 Pg. 569-571	The Release and Transdermal Penetration of Baclofen Formulated in a Poloxamer Lecithin Organogel Author(s): Arnold John J, Asbill Scott
May/Jun 2010 Pg. 204-206	Managing Pain with Transdermal Ketoprofen Author(s): Williams KaCee D
Nov/Dec 2010 Pg. 488-491	Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin Author(s): Rudner Shara, Browne Paul
Nov/Dec 2008 Pg. 546	Liothyronine Sodium (T3) 5-mcg/0.1-mL Transdermal Cream Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 295-304	Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K, Pinson Barbara, Price Carol
May/Jun 2017 Pg. 242-246	Absorption of Transdermal Fluoxetine Compounded in a Lipoderm Base Compared to Oral Fluoxetine in Client-owned Cats Author(s): Eichstadt Lauren R, Corriveau Lorraine A, Moore George E, Knipp Gregory T, Cooper Bruce R, Gwin Wilson E
Mar/Apr 2015 Pg. 167-173	Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time Author(s): Heustess Allie, Spigener Shuler, Sweitzer Sarah, Romero-Sandoval Alfonso, Asbill Scott
Sep/Oct 2018 Pg. 410	Pergolide Mesylate 0.2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
Sep/Oct 2014 Pg. 438-439	PostScription: The Future of Veterinary Compounding Author(s): Jordan Dinah G
Mar/Apr 2001 Pg. 97-100	Regulatory Issues for the Use of Bulk Drugs in Veterinary Compounding Author(s): Chan Debora Schotik
Jul/Aug 1997 Pg. 233-234	Compounding for Veterinary Patients: Pharmaceutical, Biopharmaceutical, Pharmacokinetic and Physiologic Considerations Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 270-273	Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model Author(s): Bassani August S, Banov Daniel, Lehman Paul A
Jan/Feb 2008 Pg. 67	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 111-115	Consultation for Human, Veterinary, and Compounded Medications Author(s): Moghadam Gabriella, Forsythe Lauren Eichstadt
Nov/Dec 2016 Pg. 461-467	Evaluation of the Most Frequently Prescribed Extemporaneously Compounded Veterinary Medications at a Large Independent Community Pharmacy Author(s): Karara Adel H, Hines Ryan, Demir Zehra, Nnorom Bethran, Horsey Robert, Twigg Geoffrey
Mar/Apr 2021 Pg. 143	Canine Soft Chew Base (Veterinary) Author(s): Allen Loyd V Jr
Sep/Oct 2007 Pg. 357-362	United States Pharmacopeia Convention Standards and Clinical Information for Compounded Medications Used in Veterinary Medicine Author(s): DeVeau Ian
Sep/Oct 2007 Pg. 390-395	Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients Author(s): Davidson Gigi S
Sep/Oct 2007 Pg. 412	Calculations: Compounding for Veterinary Patients Author(s): Stockton Shelly J
Nov/Dec 2006 Pg. 450-451	Standard Operating Procedure: Inventory--Veterinary Drugs and Supplies Author(s): Allen Loyd V Jr
Sep/Oct 2008 Pg. 398-401	Veterinary Compounding for Myasthenia Gravis Author(s): Davidson Gigi S
Sep/Oct 2008 Pg. 405-409	Publication Expansion of United States Pharmacopeial Convention's Veterinary Standards and Clinical Information Author(s): Neal Amy S, DeVeau Ian, Schnatz Rick G
Sep/Oct 2008 Pg. 410-413	Golden Ticket to the United States Pharmacopeial Convention's Veterinary Internship Author(s): Kirk Loren Madden
Jul/Aug 2004 Pg. 277-283	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Author(s): Davidson Gigi S
May/Jun 2005 Pg. 209-211	Survey of State Veterinary Compounding Laws and Regulations Author(s): Goodrum Jennifer
May/Jun 2005 Pg. 225	Calcitriol 100 ng/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 226	Dexamethasone Oral Powder 10-mg Units, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 227	Dipyrone 500-mg/mL Injection, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 228	Meloxicam 0.2 mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 230	Metronidazole 1% and Silver Sulfadiazine 1% Cream, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 231	Pergolide 500-mcg Capsules, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 232	Pergolide 0.2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 233	Phenoxybenzamine Hydrochloride 5-mg Capsules, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2005 Pg. 234	Piroxicam 2-mg/mL Oral Liquid, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 234	Doxycycline 166.7-mg/mL Oral Suspension (Veterinary) Author(s): Allen Loyd V Jr
May/Jun 2003 Pg. 180-183	The History of Pluronic Lecithin Organogel: An Interview With Marty Jones, BSPharm, FACA, FIACP Author(s): Allen Loyd V Jr
Sep/Oct 2002 Pg. 328-330	Total Parenteral Nutrition for Animals Author(s): Sammarco Domenic A
Jul/Aug 1997 Pg. 229	Animal Drug Delivery Systems Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 250	Antifungal for Animals Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 257	Cyclosporine Ophthalmic Drops for Animals Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 258	Hair Moisturizer/Conditioner for Horses and Other Animals Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 260	Phenolated Glycerin Otic Solution for Animals Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 261	Potassium Bromide 500-mg/mL Oral Solution for Animals Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 262	Silver Sulfadiazine 1% Otic Lotion for Animals Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 263	Sterile Vehicle for Mastitis Preparation for Animals Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 264	Sulfur and Peruvian Balsam Ointment for Mange/Ringworm for Animals Author(s): Allen Loyd V Jr
Mar/Apr 2001 Pg. 101-103	Drugs Banned for Use in Food Animals: An Explanation Author(s): Davidson Gigi S
May/Jun 1999 Pg. 188-191	When is Compounding for Animals Legal? Author(s): Siegner A Wes Jr
Nov/Dec 2023 Pg. 454-460	Highlighting the Benefits of AlpaWash in Wound Care: Case Reports in Small Animals Author(s): Semighini Flavia, Fornaciari Lais de Azevedo, Pinheiro Vanessa, Lupatini Rodrigo, Haiub Halema, Cull Erica, Sidhu Raman
Jul/Aug 2024 Pg. 278-281	Ketamine for Pain in Hospice Patients - A Transdermal Gel Applied to the Painful Site Author(s): Wood Robert M
Mar/Apr 1999 Pg. 160-163	In Vitro Transdermal Delivery and Stability of Liposome-Encapsulated Prostaglandin E1 Author(s): Foldvari Marianna, Oguejifor Cosmas
Mar/Apr 2000 Pg. 91-93	Transdermal Gels in the Treatment of Diabetic Neuropathy Author(s): Hodges Caroline J, Jones Thomas H, Willoughby David L
Sep/Oct 2000 Pg. 356 View Sample	Transdermal Nifedipine for Wound Healing: Case Reports Author(s): Torsiello Michael J, Kopacki Matthew H
Sep/Oct 2005 Pg. 354	A Patient's Guide to Transdermal Treatment of Pain Author(s): Fields Shannon W
Jul/Aug 2020 Pg. 313	Cyclobenzaprine 5-mg/g and Guaifenesin 10-mg/g Transdermal Cream Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 320	Sumatriptan, Lidocaine Hydrochloride, Dexamethasone, Pentoxifylline, and Ibuprofen Transdermal Cream (Migraine Cream) Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 198-199	U.S. Food and Drug Administration Takes Aim (Again) at Animal Compounding: Draft Guidance for Industry #256 Lacks Authority, Will Increase Costs, and Put Pets at Risk Author(s): Brunner Scott
Jan/Feb 2013 Pg. 74-85 View Sample	The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Author(s): Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K
Jan/Feb 2006 Pg. 14-18 View Sample	Transdermal Administration of Anti-inflammatory Medications in Sports Injuries: Use of Iontophoresis and Phonophoresis to Enhance Delivery Author(s): Heim Bob
Sep/Oct 2000 Pg. 386	Providing Care for Diabetic Veterinary Patients Author(s): Davidson Gigi S
Sep/Oct 2002 Pg. 324-327	Navigating New Territories in Compounding for Veterinary Medicine Author(s): Davidson Gigi S
Sep/Oct 2002 Pg. 332-336	Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs Author(s): Davidson Gigi S
Jul/Aug 2004 Pg. 303	Veterinary Wound Dressing Author(s): Allen Loyd V Jr
Sep/Oct 2004 Pg. 359-367	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 3 Author(s): Davidson Gigi S
Nov/Dec 2004 Pg. 449-450	Is Veterinary Compounding Illegal Under Federal Law? Author(s): Gibbs Jeffrey N
May/Jun 2005 Pg. 173	Book Reviews: Veterinary Drug Handbook: Client Information Edition Author(s): Reed-Kane Dana
Sep/Oct 2002 Pg. 351	Cough Ball (Veterinary) Author(s): Worthen Dennis B
May/Jun 2004 Pg. 169-172	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 1 Author(s): Davidson Gigi S
May/Jun 2004 Pg. 185	Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2007 Pg. 422	Ergonovine Maleate 0.2-mg/mL Injection, Veterinary Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 172-175	Compounding and the Specialty Veterinary Practice: An Interview with Gary Riggs, DVM, ABVP Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 180-181	Improving Profitability with Veterinary Compounding Author(s): Bradley Earl W “Bill”
May/Jun 1999 Pg. 183	The Top Ten Veterinary Compound Preparations Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 186-187	Veterinary Flavor Suggestions Author(s): Paoletti James E
Mar/Apr 2001 Pg. 134	Veterinary Antiseptic Emollient Author(s): Allen Loyd V Jr
Mar/Apr 2001 Pg. 135	Veterinary Oral Pastes Author(s): Allen Loyd V Jr
Mar/Apr 2002 Pg. 136-139	Veterinary Compounding for Ferrets Author(s): Miller Cari E
May/Jun 1998 Pg. 206	Veterinary Dexamethasone 0.1% Ophthalmic Ointment Author(s): Allen Loyd V Jr
May/Jun 1998 Pg. 206-207	Veterinary 2-deoxy-D-glucose Ophthalmic Ointment Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 223	Progesterone 100-mg/mL Veterinary Injection Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 225	Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 226	Veterinary Electrolyte Injection Author(s): Ahl Harvey
May/Jun 1999 Pg. 227	Veterinary Phenobarbital 22-mg/mL Oral Liquid Author(s): Ahl Harvey
May/Jun 2001 Pg. 214-215	Evaluating Transdermals Medication Froms for Veterinary Patients, Part 2 Author(s): Davidson Gigi S
May/Jun 2001 Pg. 216-217	The American Veterinary Medical Association Compounding Position Statement Author(s): Davidson Gigi S
Nov/Dec 1998 Pg. 420	Veterinary Considerations: COPD in Horses Author(s): Franck Paul W, Allen Cheryl, Clark Carol, Davis Jeanie
Sep/Oct 1998 Pg. 352	Model Parenteral Nutrition Formulation (Veterinary) Author(s): Allen Loyd V Jr
Sep/Oct 2002 Pg. 346-347	Excerpts from and Reviews of Current Published Literature: Veterinary Topics Author(s): Foy Elizabeth, MacCara Mary E
Sep/Oct 2002 Pg. 349	Veterinary Book Reviews Author(s): Reed-Kane Dana
Sep/Oct 2002 Pg. 372	Veterinary Carminative Author(s): Allen Loyd V Jr
Sep/Oct 2002 Pg. 374	Veterinary Penicillamine 20-mg/mL Oral Liquid, Avian Author(s): Allen Loyd V Jr
Sep/Oct 2002 Pg. 375	Veterinary Thrush Formula, Equine Author(s): Allen Loyd V Jr
Sep/Oct 2002 Pg. 376	Veterinary Topical Anesthetic and Astringent Gel Author(s): Allen Loyd V Jr
Sep/Oct 2002 Pg. 384-385	Collecting Laboratory and Other Clinical Efficacy Data on Veterinary Patients Author(s): Davidson Gigi S, Ashworth Lisa D
Mar/Apr 2001 Pg. 104	A Simplified Guide to Veterinary Compounding Author(s): Bone Claire
Mar/Apr 2001 Pg. 106	Equipment for Large-Volume Aseptic Veterinary Compounding Author(s): Ahl Harvey
Mar/Apr 2001 Pg. 107	Compounded Injectables for Veterinary Use Author(s): Yoakum Jenny
Mar/Apr 2001 Pg. 108-109	Book Reviews: Veterinary Compounding Author(s): Reed-Kane Dana
Mar/Apr 2001 Pg. 126	Diazoxide 50-mg/mL Suspension, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2001 Pg. 127	Dimethyl Sulfoxide 50% Cream, Veterinary Author(s): Allen Loyd V Jr
Mar/Apr 2001 Pg. 128	EDTA-TRIS Otic Solution V-2 (Veterinary) Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 243	Beclomethasone Dipropionate 1.25 mg/mL Aerosol Solution-Veterinary Author(s): Allen Loyd V Jr
Jul/Aug 1999 Pg. 307	Veterinary Prochlorperazine and Isopropamide Injection Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 231-232	Symposium on Veterinary Compounding: A Pivotal Meeting Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 429	Amlodipine Besylate 1 mg/mL Veterinary Suspension Author(s): Allen Loyd V Jr
Nov/Dec 2009 Pg. 559	Miconazole 1% Ophthalmic Solution, Veterinary Author(s): Allen Loyd V Jr
Jan/Feb 2026 Pg. 60	Chewable Tablet Base, Veterinary Author(s):
Jan/Feb 2026 Pg. 61	Diclazuril 333 mg/mL Oral Paste, Veterinary Author(s):
May/Jun 2024 Pg. 214-225	A Cross-sectional Online Questionnaire-based Survey About the Use of Compounded Medications in Veterinary Ophthalmology Author(s): Andrade Farah de, Saldanha André, Bastos João Thiago, Montiani-Ferreira Fabiano
May/Jun 2024 Pg. 226-227	Recommended Tips for Treating Veterinary Patients Author(s): Bramwell Bethany L, Williams LaVonn A
May/Jun 2024 Pg. 241	Calculations: Veterinary Products Author(s): Stockton Shelly J
May/Jun 2024 Pg. 242	Amlodipine Besylate Veterinary Suspension Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 243	Carprofen 2.5-mg/mL Oral Suspension, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 244	Diltiazem 5% in Lipoderm, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 245	Miconazole 1% Ophthalmic Solution, Veterinary Author(s): Allen Loyd V Jr
May/Jun 2024 Pg. 180	Prescription: Veterinary Author(s): Allen Loyd V Jr
May/Jun 1999 Pg. 176-179	Call of the Wild: Compounding for Zoos and Exotics Author(s): Hudson Sonora
May/Jun 2005 Pg. 242-246	Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
Sep/Oct 2013 Pg. 370-374	Chemical Penetration Enhancers Author(s): Newton Stephen J
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
Mar/Apr 2021 Pg. 146-155	In Vitro Permeability, Irritability, and Release Evaluation of Commonly Used Topical Diclofenac Gel Preparations (1%, 5%, and 10%) Author(s): Kohan Hamed Gilzad, Baker David M, Sani Shabnam, Bielecki-Wilken Kathleen A, Ramirez Alfonso
Sep/Oct 2022 Pg. 400-408	Basics of Compounding: Compounding with Microneedle Arrays, Part 1: Introduction and Overview Author(s): Allen Loyd V Jr
Nov/Dec 2017 Pg. 530-535	Effect of Penetration Enhancers on the Percuaneous Delivery of Hormone Replacement Actives Author(s): Trimble John O, Light Bob
Nov/Dec 2022 Pg. 490-495	Compounding with Microneedle Arrays, Part 2: Preparation and Administration Methods Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 163-167	Feasibility Study of Asthma Cream Author(s): Kuang Andrew
Nov/Dec 2016 Pg. 507	Enrofloxacin 0.5%, Ketoconazole 0.1%, and Triamcinolone Acetonide 0.1% Otic Gel Author(s): Allen Loyd V Jr
Nov/Dec 2015 Pg. 449-450	International Academy of Compounding Pharmacists' Legislative Regulatory Update: Take Action! Stop the U.S. Good and Drug Administration's Misguided Veterminary Guidance Author(s): Miller David G
Sep/Oct 2009 Pg. 440-444	Compounding Solutions for Exotic and Nondomesticated Fauna in Australia: An Investigative Study Author(s): Haywood Alison, Bolitho Richard, Gusti Kane, Yim Crystal, Testa Chris, Hattingh Laetitia
Jul/Aug 1997 Pg. 241	Compounding for Degenerative Myelopathy in the German Shepherd Author(s): Timmons Steven P
Nov/Dec 2006 Pg. 428-433	BioBullet: Innovative Pharmaceutical Compounding for Treating Cattle Author(s): Benischek Rita L
May/Jun 1999 Pg. 182-185	Compounding for Creatures: What Works Author(s): Davis Jeanie Lerche
May/Jun 1998 Pg. 206-207	Ophthalmic Compounding for Animals - Equine Ophthalmic Ointments and Treatment of Epithelial Calcification of the Cornea with EDTA 1% Author(s): Franck Paul W, Carr Randy S, Cottrill Nancy
Nov/Dec 2012 Pg. 516-523	Rice Bran Oil: Preparation and Evaluation of Novel Liquisolid and Semisolid Formulations Author(s): Ammar Hussein O, Al-Okbi Sahar Y, Mostafa Dina M, Helal Amr M
Mar/Apr 2015 Pg. 161-166	Skin Permeation and Antinociception of Compounded Topical Cyclobenzaprine Hydrochloride Formulations Author(s): Bryson Evan, Hartman Rachel, Arnold John, Gorman Greg, Sweitzer Sarah.Asbill Scott
Jan/Feb 2022 Pg. 30-32	Everything Old is New Again Author(s): Brunner Scott
Jan/Feb 2023 Pg. 30-37	Advanced Compounding: Compounding with Microneedle Arrays, Part 3: Microneedle Array Development in the Literature and Quality Control of Microneedle Arrays Author(s): Allen Loyd V Jr
Jan/Feb 2026 Pg. 23-25	Equine Protozoal Myeloencephalitis: An Ancient Parasite Meets Modern Compounding Author(s): Bethel Michelle
Nov/Dec 2011 Pg. 458-463	Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Author(s): Zur Eyal
Nov/Dec 2012 Pg. 452-455	Palliative Care and Compounding for Household Pets Author(s): Gaskins Jessica L
Sep/Oct 2020 Pg. 406	Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Author(s): Allen Loyd V Jr
Jul/Aug 1997 Pg. 236-240	Marketing to Veterinarians - Field Notes Author(s): Davis Jeanie Lerche
Jan/Feb 2000 Pg. 21-23	Fibromyalgia Author(s): Oberlander Kevin
Jan/Feb 2000 Pg. 40-41	Profile of a Practice Author(s): Davis Jeanie Lerche
Jan/Feb 2001 Pg. 55-57	Rhodococcus Equi Pneumonia in Foals Author(s): Davidson Gigi S
Jul/Aug 1999 Pg. 288-290	Profile of a Practice Author(s): Davis Jeanie Lerche
Jul/Aug 2000 Pg. 253-254	Ketamine for Pain in Hospice Patients Author(s): Wood Robert M
Jul/Aug 2002 Pg. 305	Calculations Author(s): Prince Shelly J
Mar/Apr 1999 Pg. 116-117	Profile of a Practice Author(s): Davis Jeanie Lerche
Sep/Oct 1999 Pg. 332-339	Interview: Katharina Dalton, MD: Progesterone and Related Topics Author(s): Allen Loyd V Jr
Nov/Dec 2006 Pg. 434-435	Ronidazole in the Treatment of Trichomonad Infections in Cats Author(s): Davidson Gigi S
Nov/Dec 2006 Pg. 405-408	Application of Sildenafil for Pulmonary Hypertension in Canines and Foals Author(s): Davidson Gigi S
Nov/Dec 2006 Pg. 421-424	Taurine for the Treatment of Canine Dilated Cardiomyopathy Author(s): Vail Jane
Nov/Dec 2006 Pg. 426-427	Case Report: Treatment of Canine Colitis in a Dachshund with a Compounded Oral Tri-Mix (Green Lizard) Author(s): Benischek Rita L, Riffell Gregory S, Mauldin Todd
Sep/Oct 2007 Pg. 364-374	Rabbit Medicine Author(s): Jordan Dinah G
Sep/Oct 2007 Pg. 376-383	The Whales: A Pharmacist's Story Author(s): Wills William R
Sep/Oct 2007 Pg. 384-388	Equine Cushing's Disease: A Clinical Update Author(s): Bliss George
Sep/Oct 2008 Pg. 444-445	Calculations Author(s): Stockton Shelly J
Nov/Dec 2008 Pg. 498-504	Case Reports: Compounding to Relieve Arthritis Pain Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Nov/Dec 2008 Pg. 543	Indomethacin 2% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 544	Ketorolac Tromethamine 2% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 66	Dextromethorphan Hydrobromide 10% and Guaifenesin 10% Rapidly Penetrating Gel Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 68	Diaper Rash Cream with Miconazole Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 74-77	Testing of Estradiol in a Compounded Cream and a Stock Solution Author(s): Buderer Matthew J, Buderer Nancy M
May/Jun 2009 Pg. 182-190	Update on Managing Neuropathic Pain Author(s): McNulty Jack P, Muller George
May/Jun 2009 Pg. 218-219	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
May/Jun 2009 Pg. 220-221	Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Author(s): Muller George
Jul/Aug 2009 Pg. 276-279	Hormone Treatment Options for Males: What to Do for Men with Low Testosterone Author(s): Biundo Bruce
Jul/Aug 2009 Pg. 332	Alcohol-based Carbomer Gel Author(s): Allen Loyd V Jr
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Sep/Oct 2004 Pg. 337-343	Case Report: Diagnosis and Management of Trigeminal Neuralgia and Chronic Paroxysmal Hemicrania in a 43-Year-Old Woman – Oral and Transmucosal Pharmacologic Medications Author(s): Heir Gary M, Covalesky Bernard, Karolchyk Scott
Sep/Oct 2002 Pg. 338-343	Drug Therapy for Acute and Chronic Pain in the Cat Author(s): Lascelles B Duncan
May/Jun 2003 Pg. 188-191	Treating Canine Hepatic Disease Author(s): Davidson Gigi S
Jul/Aug 2003 Pg. 250-256	A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Author(s): Gillson George R, Zava David T
Jul/Aug 2003 Pg. 294	Calculations Author(s): Prince Shelly J
Mar/Apr 2006 Pg. 95-98	ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Author(s): Moon Richard B
May/Jun 2005 Pg. 224	Calculations Author(s): Prince Shelly J
Nov/Dec 2020 Pg. 446-448	NASEM Report on Compounded Topical Pain Creams Author(s): Allen Loyd V Jr
Nov/Dec 2020 Pg. 501-508	Drug-release Assessment of Compounded Topical Nifedipine and Diltiazem in Commonly Used Bases for Wound Healing Author(s): Teimouri Arezou, Yeung Pollen, Agu Remigius U
Mar/Apr 2021 Pg. 126-128	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 8: Humectants Author(s): Allen Loyd V Jr
Jul/Aug 2020 Pg. 327-336	Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4 Author(s): Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
Sep/Oct 2020 Pg. 388-395	Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 7: Compounding with Surfactants Author(s): Allen Loyd V Jr
Jul/Aug 2017 Pg. 282-289	Simple Preparation of Timolol 0.5% Gel from Eye Drop Solution for Superficial Infantile Hemangiomas Author(s): Choo Winnie
Mar/Apr 2020 Pg. 128	Calculations Author(s): Stockton Shelly J
May/Jun 2019 Pg. 200-207	Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1 Author(s): Zur Eyal
Sep/Oct 2019 Pg. 358-364	Compounded Cyclophosphamide and Piroxicam for the Treatment of a Canine Peripheral Nerve Sheath Tumor: A Case Report Author(s): Pope George, Daleo Charles, Batson SL
May/Jun 2022 Pg. 189-193	A Compendium of Compounding Agents and Formulations, Part 3: Gentamicin Sulfate and Benzoyl Peroxide Author(s): Riepl Mike
Jul/Aug 2022 Pg. 293-296	Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases Author(s): Harrington Amy, Williams LaVonn
Sep/Oct 2022 Pg. 356	PreScription: A New Dosage Form Author(s): Allen Loyd V Jr
Sep/Oct 2022 Pg. 420	Calculations Author(s): Stockton Shelly J
Nov/Dec 2022 Pg. 480-488	A Compendium of Compounding Agents and Formulations, Part 6: Additional Preparations for Refractory Dermal-wound Healing Author(s): Riepl Mike
Jul/Aug 2021 Pg. 336-343	Compatibility of Estradiol, Estriol, Estrone, Progesterone, and Testosterone Single Formulation in Fitalite, Versatile, or HRT Supreme Cream Base Author(s): Polonini Hudson C, Dijkers Eli, Ferreira Anderson O, Zander Clark, Taylor Sarah
Sep/Oct 2021 Pg. 372-377	Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Author(s): Riepl Mike
Jan/Feb 2022 Pg. 18-23	A Compendium of Compounding Agents and Formulations, Part 1: Melatonin Author(s): Riepl Mike
Jul/Aug 2014 Pg. 345-347	Evaluation of the Stability of Promethazine Hydrochloride in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Jul/Aug 2014 Pg. 348-350	Evaluation of the Stability of Ketoprofen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita, Addo Richard T
Nov/Dec 2015 Pg. 453-463	Applying Quality of Design Concepts to Pharmacy Compounding Author(s): Timko Robert J
May/Jun 2015 Pg. 223-230	Basics of Compounding: Compounding with Silicones Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 295-300	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Nov/Dec 2016 Pg. 485-493	Basics of Compounding: Clinical Pharmaceutics, Part 2 Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 320	Mebendazole 100-mg Capsules Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Sep/Oct 2016 Pg. 412	Progesterone 10% Cream Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 137-143	Basics of Compounding: Compounding Microemulsions Author(s): Allen Loyd V Jr
Mar/Apr 2018 Pg. 153	Trilostane 5-mg/mL in Cod Liver Oil Suspension (Vet) Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 232	Anhydrous Silicon Base Topical Gel Vehicle Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 316	Anhydrous Medium-chain Triglycerides Gel Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 319	Ketoprofen 10% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Jul/Aug 2018 Pg. 322	Minoxidil 50 mg/mL in Espumil Foam Base Author(s): Allen Loyd V Jr
Sep/Oct 2018 Pg. 409	Fluoxetine 50 mg/mL in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 127-130	Basics of Compounding: 3D Printing--Pharmacy Applications, Part 1 Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 164-170	Development and Application of a High-Performance Liquid Chromatography Stability-Indicating Assay for Beyond-Use Date Determination of Compounded Topical Gels Containing Multiple Active Drugs Author(s): Gorman Gregory, Sokom Simara, Coward Lori, Arnold John J
Nov/Dec 2018 Pg. 466-468	Case Study: Absorption of Testosterone Cream via Scrotal Delivery Author(s): Needham Shawn, Needham Shane
Nov/Dec 2018 Pg. 471-473	Compounding from a Pharmacy Student's Perspective: Staying Competitive as a Compounding Pharmacy Author(s): Waldschmidt Ryan
Nov/Dec 2018 Pg. 498-503	Gabapentin in Elastic Liposomes: Preparation, Characterization, Drug Release, and Penetration Through Porcine Skin Author(s): Le Uyen Minh, Baltzley Sarah, AlGhananeem Abeer
Jul/Aug 2014 Pg. 320-321	Calculations Author(s): Stockton Shelly J
Nov/Dec 2014 Pg. 504-511	Skin Penetration and Antinociception of Topical Gabapentin Formulations Author(s): Bryson Evan, Asbill Scott, Sweitzer Sarah
Nov/Dec 2014 Pg. 512-515	In Vitro Skin Penetration and Skin Content of Progesterone from Various Topical Formulations Author(s): Heustess Allie, Asbill Scott, Eagerton David, Arnold John
Jan/Feb 2015 Pg. 6-12	Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2013 Pg. 113-123	Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Author(s): Zur Eyal
Jul/Aug 2013 Pg. 312-322	Basics of Compounding: Foam Dosage Forms Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 58-59	Calculations Author(s): Stockton Shelly J
Mar/Apr 2014 Pg. 162-168	The Standardization of Nonsterile Compounding: A Study in Quality Control and Assessment for Hormone Compounding Author(s): Wiley TS, Odegard RD, Raden J, Haraldsen JT
May/Jun 2014 Pg. 190-200	Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Author(s): McNulty John P, Muller George
May/Jun 2014 Pg. 228-230	Basics of Compounding: Tips and Hints, Part 3: Compounding with Ointments, Creams, Pastes, Gels, and Gel-creams Author(s): Allen Loyd V Jr
May/Jun 2014 Pg. 253-255	Evaluation of the Stability of Fluoxetine in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Jan/Feb 2012 Pg. 50-52 View Sample	Legislative/Regulatory Update from the International Academy of Compounding Pharmacists Author(s): Miller David G
Jan/Feb 2012 Pg. 64-68	Basics of Compounding: Implementing United States Pharmacopeia Chapter <795> Pharmaceutical Compounding–Nonsterile Preparations, Part 4 Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 386-387	Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Author(s): McElhiney Linda F
Jan/Feb 2013 Pg. 28-38	Treatment Options for Male Hypogonadism Author(s): Biundo Bruce
Sep/Oct 2012 Pg. 416	Calculations Author(s): Stockton Shelly J
Sep/Oct 2012 Pg. 428-430	Evaluation of the Stability of Acetaminophen in Pluronic Lecithin Organogel and the Determination of an Appropriate Beyond-Use Date Author(s): Peacock Gina F, Sauvageot Jurgita
Mar/Apr 2012 Pg. 125-132	A Concise Discussion of Headache Types, Part 1 Author(s): Williams LaVonn A
Jul/Aug 2012 Pg. 270-274	A Concise Discussion of Headache Types, Part 3: Migraine Author(s): Williams LaVonn A, Allen Loyd V Jr
Nov/Dec 2009 Pg. 498-505	Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Author(s): Bramwell Bethany L
Sep/Oct 2009 Pg. 410-411	Marketing Veterinarians Author(s): Moore Renee
Sep/Oct 2009 Pg. 419	Calculations Author(s): Stockton Shelly J
Jan/Feb 2010 Pg. 73	Tetracaine 4% and Menthol 5% Topical Gel Author(s): Allen Loyd V Jr
Jan/Feb 2010 Pg. 75	Trigger Point Gel Author(s): Allen Loyd V Jr
Mar/Apr 2010 Pg. 108-111	Coenzyme Q10 Supplementation in the Treatment of Heart Disease Author(s): Bramwell Bethany L
May/Jun 2010 Pg. 182-192	Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Author(s): Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III
May/Jun 2010 Pg. 200-203	Topical Medications for Orofacial Neuropathic Pain Author(s): Bramwell Bethany L
Sep/Oct 2008 Pg. 384-390	Canine Public Servants: Caring for Drug Detection Dogs Author(s): Davidson Gigi S
Nov/Dec 2008 Pg. 540	Cyclobenzaprine Hydrochloride 0.5% and Diclofenac Sodium 3% in Pluronic Lecithin Organogel Author(s): Allen Loyd V Jr
Nov/Dec 2008 Pg. 541	Cyclobenzaprine Hydrochloride 1%, Dextromethorphan Hydrobromide 10%, Guaifenesin 10%, and Indomethacin 20% Penetrating Gel Author(s): Allen Loyd V Jr
Sep/Oct 2009 Pg. 362-365	Little Thief: The Domestic Ferret Author(s): Benischek Rita L
Jan/Feb 2011 Pg. 62	Calculations Author(s): Stockton Shelly J
Sep/Oct 2010 Pg. 419	Calculations Author(s): Stockton Shelly J
Sep/Oct 2010 Pg. 422	Icy Blue Camphorated Gel Author(s): Allen Loyd V Jr
Jul/Aug 2010 Pg. 310-314	Unique Challenges in Compounding: Managing Severe Musculoskeletal Pain in a Recovered Substance Abuser Author(s): Christiansen Joel, White Lyndell
May/Jun 2010 Pg. 210-213	Potential Treatments for Radiation Dermatitis Author(s): Corsini Lindsay
May/Jun 2010 Pg. 215-217	Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report Author(s): Muller George
May/Jun 2010 Pg. 230	Calculations Author(s): Stockton Shelly J
Nov/Dec 2009 Pg. 558	Lubow's Solution Author(s): Allen Loyd V Jr
Jan/Feb 2026 Pg. 26-31	Why Compounded Medications Matter in Wild Life Medicine: A Pharmacist's Perspective Author(s): Brand Triena
Nov/Dec 2025 Pg. 495-504	Personalized Orodispersible Films Compounded with OrPhyllo™ Ready-to-use Base: API Compatibility and Evidence-Based Beyond-Use Dates Author(s): Kegele Carolina Schettino, Marianni Bruna, Polonini Hudson
May/Jun 2023 Pg. 208-210	Show Me the Science: A Perspective Author(s): Grzib Anthony
May/Jun 2023 Pg. 218-221	Nonsterile Basics of Compounding: Compounding with Humectants Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 508	Bacitracin 0.01% and Phenol 0.1% in Cetaphil Lotion Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 509	Curcumin 2% Topical Gel Author(s): Allen Loyd V Jr
Sep/Oct 2023 Pg. 362-366	Compounding Metformin for Use in Functional Medicine Author(s): Desai Sarina, Thompson Tara
Jan/Feb 2024 Pg. 6-14	Treatment Options for Male Hypogonadism Author(s): Biundo Bruce
Jan/Feb 2024 Pg. 28-32	Hormone Treatment Options for Males: What to do for Men with Low Testosterone Author(s): Biundo Bruce
Mar/Apr 2024 Pg. 111-116	Efficacy and Clinical Value of Commonly Used Ingredients in Pain Management Compounds: A Literature Review Author(s): Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi
Mar/Apr 2024 Pg. 118-119	Safe Use of Topical Local Anesthetic Medications for Pain Management Author(s): Epshteyn Mikhail G, Pepin Steven M
Mar/Apr 2007 Pg. 126-130	Including Pets in Diabetic Care Author(s): Davidson Gigi S
Mar/Apr 2007 Pg. 106-110	Compounding for the Complications of Diabetes: Interviews with Compounding Pharmacists George B. Muller, RPh, and Jerrod Roberts, DPh Author(s): Vail Jane

Name:
Email:
Organization:
Used For:

Related Articles